514 related articles for article (PubMed ID: 12208249)
1. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
3. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
4. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Lecube A; Segura RM; Sararols L; Simó R
Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
[TBL] [Abstract][Full Text] [Related]
6. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
[TBL] [Abstract][Full Text] [Related]
7. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
[TBL] [Abstract][Full Text] [Related]
8. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H; Yamashita H; Nakanishi Y; Hori S
Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
[TBL] [Abstract][Full Text] [Related]
10. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
Funatsu H; Yamashita H; Noma H; Mochizuki H; Mimura T; Ikeda T; Hori S
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1042-7. PubMed ID: 12601027
[TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
Zhou H; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
[TBL] [Abstract][Full Text] [Related]
13. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
14. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
15. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
[TBL] [Abstract][Full Text] [Related]
16. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
18. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
[TBL] [Abstract][Full Text] [Related]
19. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
